MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Carcinoma, Basal Cell

(UMLS:C4721806)

Definition:: A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471)
UMLS ID:: C4721806
MeSH ID:: D002280

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.470.200.165|C04.557.470.565.165

Synonym(s)

Carcinoma, Basal Cell

BASAL CELL CARCINOMA

BASAL CELL CARCINOMA OF SKIN

BASAL CELL EPITHELIOMA

BCC - Basal cell carcinoma of skin

Basal Cell Cancer

Basal Cell Carcinoma

Basal Cell Carcinoma of Skin

Basal Cell Carcinoma of the Skin

10.

Basal Cell Epithelioma

11.

Basal Cell Skin Carcinoma

12.

Basal cell carcinoma

13.

Basal cell carcinoma of skin

14.

Basal cell carcinoma, NOS

15.

Basal cell carcinomas

16.

Basal cell epithelioma

Associated Drug(s)

	Name	Reference(s)	Data Source
1	Arecoline	22108589	CTD
2	Arsenicals	15504454 17687452	CTD
3	Azathioprine	18854826	CTD
4	Doxorubicin	2224762	CTD
5	Ficusin	11511317	CTD
6	HhAntag691	25559776	CTD
7	Imiquimod	16302556 17052533 31111189	CTD
8	Methotrexate	4058741	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Carcinoma, Papillary	58.1%
2	Squamous cell carcinoma	58.1%
3	Cystadenocarcinoma	49%
4	Mucoepidermoid Carcinoma	49%
5	Adenocarcinoma	47.3%
6	Carcinoma in Situ	47.3%
7	Carcinoma, Transitional Cell	47.3%
8	Carcinoma, Large Cell	47.3%
9	Carcinoma, Small Cell	47.3%
10	Adenoma	45.7%
11	Cystadenoma	45.2%
12	Mesothelioma	45.2%
13	Carcinoma, Ehrlich Tumor	44.6%
14	Carcinoma, Lewis Lung	44.6%
15	Bowen's Disease	43.2%
16	Neoplasms, Neuroepithelial	42.9%
17	Gliomatosis cerebri	42.9%
18	Carcinoma, Lobular	36.1%
19	Adenoid Cystic Carcinoma	35.3%
20	Adenocarcinoma, Clear Cell	35.3%
21	Cholangiocarcinoma	35.3%
22	Cervical Intraepithelial Neoplasia	35.3%
23	leukemia	33.3%
24	Neoplasms, Germ Cell and Embryonal	33.3%
25	Germ Cell Cancer	33.3%
26	Carcinoid Tumor	32.6%
27	Papilloma	30.1%
28	Pseudomyxoma Peritonei	30.1%
29	Papillomatosis	30.1%
30	Adenomatosis, Pulmonary	30.1%
31	Adenomatous Polyps	30.1%
32	Neuroectodermal Tumors	29.5%
33	Adenoma, Acidophil	29.5%
34	Ganglioneuroma	29.5%
35	Glioma	29.5%
36	Malignant Glioma	29.5%
37	Klatskin Tumor	29.3%
38	Medulloblastoma	28.6%
39	Adenofibroma	28.5%
40	Fibroadenoma	28.5%
41	Acanthoma	27.6%
42	Choriocarcinoma	27.5%
43	Malignant Carcinoid Syndrome	27%
44	Histiocytic Disorders, Malignant	25%
45	Carcinosarcoma	24.4%
46	Hemangiosarcoma	24.4%
47	lymphangiosarcoma	24.4%
48	melanoma	23.2%
49	Astrocytoma	22.9%
50	Ependymoma	22.9%
51	oligodendroglioma	22.9%
52	Ganglioglioma	22.9%
53	gliosarcoma	22.9%
54	Anaplastic astrocytoma	22.9%
55	Anaplastic Oligodendroglioma	22.9%
56	Carcinoma	22.8%
57	Epithelioma	22.8%
58	Basal cell carcinoma	22.6%
59	Carcinoma, Basal Cell	22.6%
60	Meningioma	21.1%
61	Hamartoma	20.9%
62	Neoplasms, Hormone-Dependent	20.9%
63	Neoplasms, Multiple Primary	20.9%
64	Paraneoplastic Syndromes	20.9%
65	Precancerous Conditions	20.9%
66	Neoplasms, Second Primary	20.9%
67	Carcinoid Heart Disease	20.6%
68	Carcinoma, Pancreatic Ductal	20.4%
69	Carcinoma 256, Walker	20.3%
70	Lymphoma	20%
71	Glioblastoma	19.7%
72	Neuroblastoma	19.7%
73	Glioblastoma Multiforme	19.7%
74	Ameloblastoma	19.6%
75	Angiokeratoma	19.6%
76	Chordoma	19.6%
77	Hemangioma	19.6%
78	hemangiopericytoma	19.6%
79	Lymphangioma	19.6%
80	Mesenchymoma	19.6%
81	Nevus	19.6%
82	Teratoma	19.6%
83	Hepatoblastoma	19.6%
84	Mixed Tumor, Mullerian	19.6%
85	Germinoma	19.6%
86	Teratocarcinoma	19.6%
87	Angiofibroma	19.6%
88	Composite Lymphoma	19.6%
89	Sarcoma	19.6%
90	Leukemia, Plasma Cell	19.5%
91	Chondrosarcoma	19.4%
92	Craniopharyngioma	19.4%
93	leiomyosarcoma	19.4%
94	liposarcoma	19.4%
95	synovial sarcoma	19.4%
96	Neuroectodermal Tumor, Melanotic	19.4%
97	Angiomyolipoma	19.4%
98	Clear Cell Sarcoma of Soft Tissue	19.4%
99	Alveolar Soft Part Sarcoma	19.4%
100	Neuroendocrine Tumors	19.4%
101	Sarcoma, Myeloid	19.4%
102	Carcinoma, Ovarian Epithelial	19.3%
103	Trophoblastic Neoplasms	18.7%
104	Leukemia, Experimental	18.5%
105	Dermoid Cyst	18.2%
106	Retinoblastoma	18.2%
107	Ganglioneuroblastoma	18.1%
108	Hepatocellular Adenoma	17.4%
109	Neurilemmoma	17.3%
110	Hutchinson's Melanotic Freckle	17.3%
111	Melanoma, Amelanotic	17.3%
112	Melanoma, Experimental	17.2%
113	Fibrosarcoma	16.9%
114	Osteosarcoma	16.9%
115	Nasopharyngeal carcinoma	16.6%
116	Adrenocortical carcinoma	16.5%
117	Cyst	15.8%
118	Neoplastic Processes	15.8%
119	Neoplastic Syndromes, Hereditary	15.8%
120	Pregnancy Complications, Neoplastic	15.8%
121	Leukemia, Radiation-Induced	15.6%
122	Malignant Fibrous Histiocytoma	15.6%
123	Neoplasms, Experimental	15.5%
124	Prolactinoma	14.8%
125	Growth Hormone-Secreting Pituitary Adenoma	14.8%
126	Plasmacytoma	14.8%
127	Malignant histiocytosis	14.6%
128	Leukemia L1210	14.6%
129	Leukemia P388	14.6%
130	Histiocytic sarcoma	14.6%
131	Vipoma	14.6%
132	Sarcoma, Experimental	14.5%
133	Endometrial Stromal Sarcoma	14.4%
134	Renal Cell Carcinoma	14.4%
135	Paraganglioma	14.4%
136	Rhabdomyosarcoma	14.4%
137	Giant Cell Tumor of Bone	14.4%
138	Papillary Renal Cell Carcinoma	14.4%
139	Thymoma	14.4%
140	Carcinoma, Endometrioid	14.1%
141	Gastrinoma	13.4%
142	Glucagonoma	13.4%
143	Dermatofibrosarcoma	13.2%
144	Dermatofibrosarcoma Protuberans	13.2%
145	Phyllodes Tumor	12.9%
146	Dysgerminoma	12.9%
147	Hemangioendothelioma	12.9%
148	Lipoma	12.9%
149	Myoma	12.9%
150	Myxoma	12.9%
151	Neuroma	12.9%
152	Seminoma	12.9%
153	Angiolipoma	12.9%
154	Myelolipoma	12.9%
155	Neoplasms, Bone Tissue	12.9%
156	Neoplasms, Fibrous Tissue	12.9%
157	Smooth Muscle Tumor	12.9%
158	Desmoplastic Small Round Cell Tumor	12.9%
159	Lymphangioleiomyomatosis	12.9%
160	Chondroma	12.9%
161	Enchondroma	12.9%
162	Multiple Endocrine Neoplasia	12.6%
163	Neoplasms, Radiation-Induced	12.4%
164	Sarcoma 180	12.1%
165	Pheochromocytoma	12%
166	Alveolar rhabdomyosarcoma	12%
167	Hodgkin Disease	11.7%
168	Lymphoma, Non-Hodgkin	11.7%
169	Neurofibrosarcoma	11.6%
170	Abdominal Neoplasms	11.1%
171	Erythroplasia	11.1%
172	Follicular cyst	11.1%
173	Head and Neck Neoplasms	11.1%
174	Mucocele	11.1%
175	Pilonidal Cyst	11.1%
176	Soft Tissue Neoplasms	11.1%
177	Thoracic Neoplasms	11.1%
178	Thyroglossal Cyst	11.1%
179	Synovial Cyst	11.1%
180	Aberrant Crypt Foci	11.1%
181	Optic Nerve Glioma	11.1%
182	insulinoma	10.8%
183	Paraneoplastic Encephalomyelitis	10.8%
184	Mammary Neoplasms, Experimental	10.6%
185	Lymphomatoid Granulomatosis	10.3%
186	Nephroblastoma	10.1%
187	Basal Cell Nevus Syndrome	10.1%
188	Adenomatous Polyposis Coli	9.8%
189	Primary amyloidosis	9.8%
190	Leukemia, Myelomonocytic, Chronic	9.7%
191	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	9.7%
192	fibroma	9.6%
193	Fibromatosis	9.6%
194	Osteoblastoma	9.6%
195	Osteoma	9.6%
196	Rhabdomyoma	9.6%
197	Chondromatosis	9.6%
198	Hemangioblastoma	9.6%
199	Lymphoma, Extranodal NK-T-Cell	9.6%
200	Tuberous Sclerosis	9.2%
201	Digestive System Neoplasms	8.8%
202	Endocrine Gland Neoplasms	8.8%
203	Eye Neoplasms	8.8%
204	Nervous System Neoplasms	8.8%
205	Acoustic Neuroma	8.7%
206	Bone neoplasms	8.5%
207	Leukoplakia	8.5%
208	Lymphocele	8.5%
209	Pancreatic Cyst	8.5%
210	Skin Neoplasms	8.5%
211	Hematologic Neoplasms	8.5%
212	Mesoblastic Nephroma	8.5%
213	Barrett Esophagus	8.3%
214	Breast Cyst	8.3%
215	Hydatidiform Mole	8.3%
216	Actinic keratosis	8.3%
217	Mediastinal Cyst	8.3%
218	Neoplasm Invasiveness	8.3%
219	Neoplasm Metastasis	8.3%
220	Neoplasm Recurrence, Local	8.3%
221	Parovarian Cyst	8.3%
222	Pericardial Cyst	8.3%
223	Splenic Neoplasms	8.3%
224	Thymic Cyst	8.3%
225	Carcinogenesis	8.3%
226	Myxoid cyst	8.3%
227	Metastasis	8.3%
228	Fibromatosis, Aggressive	8%
229	Fibromatosis, Abdominal	8%
230	Mastocytosis	7.9%
231	Sturge-Weber Syndrome	7.9%
232	Gastrointestinal Stromal Tumors	7.8%
233	Hemangioma, Cavernous	7.8%
234	Leukemia, T-Cell	7.7%
235	Leukemia, B-Cell	7.7%
236	neurofibroma	7.7%
237	Lymphoma, Follicular	7.7%
238	T-Cell Lymphoma	7.7%
239	Mantle cell lymphoma	7.7%
240	Multiple Endocrine Neoplasia Type 1	7.5%
241	Waldenstrom Macroglobulinemia	7.4%
242	Multiple Myeloma	7.4%
243	Mastocytoma	7.3%
244	Mastocytosis, Systemic	7.2%
245	Leukemia, Myeloid, Chronic-Phase	7.2%
246	Parathyroid Neoplasms	6.7%
247	Peritoneal Neoplasms	6.7%
248	Thyroid Neoplasm	6.7%
249	Thyroid carcinoma	6.7%
250	Liver Neoplasms, Experimental	6.6%
251	Corpus Luteum Cyst	6.6%
252	Ovarian Cysts	6.6%
253	Retroperitoneal Neoplasms	6.5%
254	granulosa cell tumor	6.4%
255	Pancreatic Neoplasm	5.8%
256	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	5.8%
257	Leukemia, Large Granular Lymphocytic	5.8%
258	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	5.8%
259	Lymphoma, T-Cell, Cutaneous	5.7%
260	Lymphoma, AIDS-Related	5.7%
261	Enteropathy-Associated T-Cell Lymphoma	5.7%
262	Primary Effusion Lymphoma	5.7%
263	Choledochal Cyst	5.6%
264	Tracheal Neoplasms	5.6%
265	Peutz-Jeghers Syndrome	5.5%
266	Leukoplakia, Oral	5.5%
267	Paraneoplastic Cerebellar Degeneration	5.4%
268	Leydig Cell Tumor	5.1%
269	Mouth Neoplasms	5%
270	Central Nervous System Neoplasms	5%
271	Vascular Neoplasms	5%
272	Thymus Neoplasms	5%
273	Dupuytren Contracture	4.9%
274	Genital Neoplasms, Female	4.9%
275	Pancreatic Pseudocyst	4.9%
276	Lymphatic Metastasis	4.9%
277	Neoplasms, Unknown Primary	4.9%
278	Leukemic Infiltration	4.9%
279	Breast Neoplasms, Male	4.9%
280	Neoplasm Micrometastasis	4.9%
281	Triple Negative Breast Neoplasms	4.9%
282	Urticaria Pigmentosa	4.8%
283	Mycosis Fungoides	4.8%
284	Lymphomatoid Papulosis	4.8%
285	Plasmablastic lymphoma	4.8%
286	Esophageal Neoplasms	4.7%
287	Denys-Drash Syndrome	4.7%
288	Limbic Encephalitis	4.7%
289	Thyroid Nodule	4.3%
290	Lambert-Eaton Myasthenic Syndrome	4.1%
291	Testicular Neoplasms	4.1%
292	Burkitt Lymphoma	4.1%
293	Adrenal Gland Neoplasms	4.1%
294	Gastrointestinal Neoplasms	4.1%
295	Genital Neoplasms, Male	4.1%
296	Liver neoplasms	4.1%
297	Uveal Neoplasms	4.1%
298	Urologic Neoplasms	4%
299	Sebaceous Gland Neoplasms	3.9%
300	Spinal Neoplasms	3.9%
301	Bone Marrow Neoplasms	3.9%
302	Polycystic Ovary Syndrome	3.9%
303	Opsoclonus-Myoclonus Syndrome	3.7%
304	Sezary Syndrome	3.4%
305	Xeroderma Pigmentosum	3.3%
306	Myelitis, Transverse	3.3%
307	Meningeal Neoplasms	3.3%
308	Nose Neoplasms	3%
309	Palatal Neoplasms	2.8%
310	ovarian neoplasm	2.8%
311	Pituitary Adenoma	2.7%
312	Pituitary Neoplasms	2.7%
313	Ear Neoplasms	2.7%
314	Eyelid Neoplasms	2.7%
315	Lung Neoplasms	2.7%
316	Pleural Neoplasms	2.7%
317	Cell Transformation, Viral	2.6%
318	Brain Neoplasms	2.6%
319	Salivary Gland Neoplasms	2.6%
320	Spinal Cord Neoplasms	2.6%
321	Tongue Neoplasms	2.6%
322	Uterine Neoplasms	2.6%
323	Vaginal Neoplasms	2.6%
324	Vulvar Neoplasms	2.6%
325	Uterine Cancer	2.6%
326	Fallopian Tube Neoplasms	2.6%
327	Meningeal Carcinomatosis	2.4%
328	Pharyngeal Neoplasms	2.3%
329	Central Nervous System Cysts	2.2%
330	Bile Duct Neoplasms	2.2%
331	gallbladder neoplasm	2.2%
332	Intestinal Neoplasms	2.2%
333	Penile Neoplasms	2.2%
334	Prostatic Neoplasms	2.2%
335	Stomach Neoplasms	2.2%
336	Zollinger-Ellison syndrome	2.2%
337	Polycythemia Vera	2.2%
338	Bronchial Neoplasms	2%
339	Multiple Pulmonary Nodules	2%
340	Laryngeal neoplasm	2%
341	Supratentorial Neoplasms	1.9%
342	Endometrial Neoplasms	1.9%
343	Bladder Neoplasm	1.9%
344	Kidney Neoplasm	1.9%
345	Ureteral Neoplasms	1.9%
346	Urethral Neoplasms	1.9%
347	Hypopharyngeal Neoplasms	1.6%
348	Pleural Effusion, Malignant	1.6%
349	Hypopharyngeal Cancer	1.6%
350	Parotid Neoplasms	1.6%
351	Prostatic Neoplasms, Castration-Resistant	1.6%
352	Nelson Syndrome	1.6%
353	Brain Stem Neoplasms	1.6%
354	Choroid Plexus Papilloma	1.4%
355	Cecal Neoplasms	1.4%
356	Duodenal Neoplasms	1.4%
357	Tonsillar Neoplasms	1.3%
358	Cerebellar Neoplasms	1.3%
359	Nasopharyngeal Neoplasms	1.2%
360	Colorectal Neoplasms	1.2%
361	Radicular Cyst	1.1%
362	Appendiceal Neoplasms	1.1%
363	Colonic Neoplasms	1.1%
364	Rectal Neoplasms	1.1%
365	Paranasal Sinus Neoplasms	1.1%
366	Maxillary Sinus Neoplasms	0.9%
367	Anus Neoplasms	0.9%
368	Sigmoid Neoplasms	0.9%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234